An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial—an update to the published protocol

This article reports an update to the protocol of the IMASOY trial, which was prospectively registered on clinicaltrials.gov (NCT04110340) in October 2019.

Bibliographic Details
Main Authors:	Randremanana, RV, Raberahona, M, de Dieu Randria, MJ, Bourner, J, Zadonirina, G, Razananaivo, H, Mayouya-Gamana, T, Mangahasimbola, R, Pesonel, E, Gillesen, A, Rajerison, M, Andrianaivoarimanana, V, Edwards, T, Horby, P, Olliaro, P
Format:	Journal article
Language:	English
Published:	BioMed Central 2024

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial—an update to the published protocol

Similar Items